PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2014

Interleukin-33 treatment reduces secondary injury and improves functional recovery after contusion spinal cord injury.

Mouse / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 25153903 ↗2014Reported benefit

Interleukin-33 treatment reduces secondary injury and improves functional recovery after contusion spinal cord injury.

MouseSpinal cord injuryContusionC57BL/6Female

Model: Contusion spinal cord injury

Interleukin-33 was upregulated with nuclear localisation predominantly in astrocytes after injury. Recombinant interleukin-33 treatment reduced tissue loss, demyelination and astrogliosis and markedly improved functional recovery, with persistent M2 microglia and macrophage activation and a periphe…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.65. Machine-extracted fields require source verification.